---
product_id: 8698670
title: "The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for the non-scientist) Paperback – February 24, 2010"
brand: "t. ayers pelz"
price: "NT$2538"
currency: TWD
in_stock: true
reviews_count: 10
url: https://www.desertcart.tw/products/8698670-the-biotech-trader-handbook-2nd-edition-a-fast-simplified-efficient
store_origin: TW
region: Taiwan
---

# The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for the non-scientist) Paperback – February 24, 2010

**Brand:** t. ayers pelz
**Price:** NT$2538
**Availability:** ✅ In Stock

## Quick Answers

- **What is this?** The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for the non-scientist) Paperback – February 24, 2010 by t. ayers pelz
- **How much does it cost?** NT$2538 with free shipping
- **Is it available?** Yes, in stock and ready to ship
- **Where can I buy it?** [www.desertcart.tw](https://www.desertcart.tw/products/8698670-the-biotech-trader-handbook-2nd-edition-a-fast-simplified-efficient)

## Best For

- t. ayers pelz enthusiasts

## Why This Product

- Trusted t. ayers pelz brand quality
- Free international shipping included
- Worldwide delivery with tracking
- 15-day hassle-free returns

## Description

Full description not available

## Images

![The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for the non-scientist) Paperback – February 24, 2010 - Image 1](https://m.media-amazon.com/images/I/51aj5mFh0aL.jpg)

## Customer Reviews

### ⭐⭐⭐⭐⭐ 5.0 out of 5 stars







  
  
    Outstanding book
  

*by T***E on Reviewed in the United States on September 28, 2012*

This book is not very thick, but the author packs into it an extreme amount of valuable data on how to select, time, and invest in biotech stocks.  The author shows you specific methods for researching and selecting your biotech investments, without having to have any type of indepth knowledge in the biotech world.  He even gives you advice on organizing your research data. The author then goes on in providing different detail methods in evaluating and implementing your investments.  The author provides clear cut examples of how to make your biotech investments using options (both puts and calls) and how to hedge your investments to minimize risks while maximizing potential gains.The author does assume you have an existing knowledge of options, and he tells you this early in the book.  If you do not have an indepth knowledge and understand of options and the different option strategies (which I did not) I still highly recommend this book.  Then do like I did and find a separate book that simply deals with learning to understand options.If you are like me though and are thinking about focusing on biotech investing, or perhaps are already investing in biotechs, and want to learn how to improve your results while hedging against the risks... then I highly, highly recommend this book.  I definitely feel it is the best investment I have ever made on the subject of investing in biotechs.One last comment, to those reading my review:  I have absolutely no connection with the author, the publisher, or any other associated party related to this book.  I am simply an individual investor that was, and is, trying to continue to advance my knowledge and improve my own investing skills.  I simply came across this book on Amazon, while looking to see what books were available on biotech investing.

### ⭐⭐⭐⭐⭐ 5.0 out of 5 stars







  
  
    The biotech trader hadbook second eddition exopabdeded
  

*by R***F on Reviewed in the United States on April 9, 2011*

I my profession I try to understand the meaning  of the words that surround me, to digest and implement new information, and act on it preferably  by changing may behavior TODAY!Life is to shot  I read  about ten books in options, but which is the best?I think the books are like an exercise machines most of them collect dust in the corner, except for ones that you actually use. Some of the books I was not able to understand because of my limited mathematical knowledge, but the majority are written in very confused languish, by brilliant people that have no practical use in real world of none professional trader.  As I Professor of Psychiatry of 30 years affiliation with  Ivy League Medical Schools I noticed that highly intelligent people write very simple, like Freud or almost incomprehensible like Schopenhauer.Tony book is the smallest of all books; it's like a little shiny diamond written in very undestandle and usable way. He writes: To estimate price movement we add Call premium and Put premium we get 5, 95(=2, 75+3.2).Now we subtract and add the total premium value to the correct share of the price of XYZ  $ 7.5 to get 1.55 and 13.54I am waiting for kidle eddition

### ⭐⭐⭐ 3.0 out of 5 stars







  
  
    Is it missing some chapters??
  

*by N***N on Reviewed in the United States on March 16, 2010*

The book seems to be missing some chapters?!?! For example, how exactly to 'handicap' a phase III trial? It goes into no detail on the though process to establish a bullish, bearish, or neutral bias. Although it does clearly explain the ancillary information that might be required in analyzing a biotech company (cash burn, potential value, insider activity, and potential dates) it has no chapter or discussion on how to even begin to determine if a specific drug will pass/fail Phase III trial. Now granted that may be impossible to do in reality with a high degree of probability, but there is not a single case study of a trade to go through the entire process.  Also missing is any discussion of how to obtain analysts estimates as a retail trader since most is only available to institutional clients.That being said the book does do a decent enough job explaining what it does have chapters on including analyzing the cash positions of a firm and creating trading strategies around a specific bias. Unfortunately it never goes into how to exactly establish the bias via explanation or case studies.Finally the author alludes to many possible potential short term trading opportunities such as a tendency for stocks and volatility around or after a specific announcement, but never elaborates on any. A chapter on this alone would've been worth 10x the price.Mr Pelz has done a pretty good job with this one but it's only HALF COMPLETE. If the author reads this, please contact me!

---

## Why Shop on Desertcart?

- 🛒 **Trusted by 1.3+ Million Shoppers** — Serving international shoppers since 2016
- 🌍 **Shop Globally** — Access 737+ million products across 21 categories
- 💰 **No Hidden Fees** — All customs, duties, and taxes included in the price
- 🔄 **15-Day Free Returns** — Hassle-free returns (30 days for PRO members)
- 🔒 **Secure Payments** — Trusted payment options with buyer protection
- ⭐ **TrustPilot Rated 4.5/5** — Based on 8,000+ happy customer reviews

**Shop now:** [https://www.desertcart.tw/products/8698670-the-biotech-trader-handbook-2nd-edition-a-fast-simplified-efficient](https://www.desertcart.tw/products/8698670-the-biotech-trader-handbook-2nd-edition-a-fast-simplified-efficient)

---

*Product available on Desertcart Taiwan*
*Store origin: TW*
*Last updated: 2026-03-16*